EUVIMEDOpdag EUVIMED
Open access

Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy

Shaoxiong Ning, Qian Zhang, Zhixing Shang, Hongting Liu

American Journal of Translational Research · 2026 · 18 (6) · 4777-4790

DOI: 10.62347/hhhf9971 ↗

At a glance

Journal article in American Journal of Translational Research, 2026. Written by Shaoxiong Ning and 3 co-authors. Institution: Department of Nephrology, Yuncheng Central Hospital Yuncheng 044000, Shanxi, China. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

Author keywords

B-cell depletion therapyObinutuzumabanti-PLA2R antibodyclinical remissionidiopathic membranous nephropathy

Authors and institutions

  • Department of Nephrology, Yuncheng Central Hospital Yuncheng 044000, Shanxi, China.
  • Department of Cardiology, Yuncheng Central Hospital Yuncheng 044000, Shanxi, China.

Cite

APA

Ning, S., Zhang, Q., Shang, Z., & Liu, H. (2026). Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy. American Journal of Translational Research, 18(6), 4777-4790. https://doi.org/10.62347/hhhf9971

Vancouver

Ning S, Zhang Q, Shang Z, Liu H. Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy. American Journal of Translational Research. 2026;18(6):4777-4790. doi:10.62347/hhhf9971

BibTeX
@article{Ning2026,
  author = {Ning, Shaoxiong and Zhang, Qian and Shang, Zhixing and Liu, Hongting},
  title = {Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy},
  journal = {American Journal of Translational Research},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {4777--4790},
  doi = {10.62347/hhhf9971}
}
Start for free →